GlassScriptPhysician profile
Andreea A Barcan
NPI 1326483199
$9,196.27
in general payments reported to CMS, 2019-2025
35 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,580 · 2022: $1,435 · 2023: $1,554 · 2024: $2,353 · 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,109 · Education: $72.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,108.78 |
| Education | $72.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,359.73 | 2021-2025 | |
| Ucb, INC. | $1,054.42 | 2021-2025 | Briviact, Zilbrysq, Rystiggo |
| Eisai INC. | $1,023.85 | 2021-2025 | |
| Ge Healthcare | $929.77 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $877.20 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lilly USA, LLC | $488.04 | 2021-2025 | Kisunla, Amyvid, Reyvow |
| Alnylam Pharmaceuticals INC. | $333.77 | 2022-2024 | Onpattro |
| Biogen, INC. | $319.66 | 2021-2025 | Vumerity |
| Lundbeck LLC | $310.49 | 2023-2025 | Vyepti, Rexulti |
| Amgen INC. | $284.24 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $234.38 | 2022 | |
| Avanir Pharmaceuticals, INC. | $217.60 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $200.46 | 2023-2024 | Nuedexta, Rexulti |
| Biohaven Pharmaceuticals, INC. | $190.21 | 2021 | |
| Pfizer INC. | $175.59 | 2023-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $173.37 | 2021-2025 | Valtoco |
| Sk Life Science, INC. | $159.93 | 2021-2024 | |
| Amneal Pharmaceuticals LLC | $116.27 | 2021-2025 | Rytary, Crexont |
| Argenx US, INC. | $113.76 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Corium, LLC | $96.40 | 2022-2023 | Azstarys, Adlarity |
| Acadia Pharmaceuticals INC | $71.75 | 2023-2025 | Nuplazid |
| Avion Pharmaceuticals | $69.08 | 2022-2023 | Dhivy |
| Supernus Pharmaceuticals, INC. | $55.94 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $52.55 | 2021 | |
| Neurocrine Biosciences, INC. | $47.44 | 2023-2025 | Ingrezza, Ongentys |
| Janssen Biotech, INC. | $37.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.33 | 2021 | |
| Averitas Pharma INC. | $30.68 | 2023 | Qutenza |
| Upsher-Smith Laboratories LLC | $28.86 | 2021 | |
| Impel Pharmaceuticals INC. | $26.91 | 2022 | |
| Abbott Laboratories | $23.54 | 2023 | Infinity |
| Harmony Biosciences LLC | $16.35 | 2025 | |
| Allergan, INC. | $15.68 | 2021 | |
| Merz Pharmaceuticals, LLC | $14.45 | 2025 | Inbrija, Xeomin |
| Aquestive Therapeutics, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreea Barcan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.